Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sara Bouberhan, M.D.

Concepts (70)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms5202349040.850 Why?
Platinum220192190.730 Why?
Genital Neoplasms, Female220215340.570 Why?
Financing, Personal120193100.540 Why?
Vulvar Neoplasms220222650.340 Why?
Cost of Illness1201919490.320 Why?
Health Expenditures1201923890.260 Why?
Patient Acceptance of Health Care1201932290.240 Why?
Drug Resistance, Neoplasm1201953340.230 Why?
Neoplasm Recurrence, Local3202293780.210 Why?
Endometrial Neoplasms2202213790.210 Why?
Phthalazines220223970.170 Why?
Reactive Oxygen Species1202321440.120 Why?
Rectum120198960.110 Why?
Hysterectomy120198640.110 Why?
Ribose22023630.100 Why?
Acute Kidney Injury1202319430.090 Why?
Income1201918740.090 Why?
Disclosure120167560.090 Why?
Disease Management1201925300.080 Why?
Patient Preference120169460.080 Why?
Adaptation, Psychological1201926620.070 Why?
Piperazines1201825470.070 Why?
Female1120233961580.070 Why?
Self Report1201937690.070 Why?
Carcinoma, Squamous Cell1202240470.070 Why?
Insurance, Health1201925200.070 Why?
Lymph Node Excision2202212620.070 Why?
Ligands2202232740.060 Why?
Humans1420237660000.060 Why?
Diphosphates12022910.050 Why?
Poly(ADP-ribose) Polymerases120234280.050 Why?
Neoplasms22022223360.040 Why?
Cross-Sectional Studies22019262800.040 Why?
Carboplatin120237870.040 Why?
Antineoplastic Agents12023136340.040 Why?
Hydrogen Peroxide120237400.040 Why?
DNA Mismatch Repair120224320.040 Why?
Prognosis12019299040.040 Why?
Sentinel Lymph Node Biopsy120227330.040 Why?
Middle Aged420212230250.040 Why?
Neoplasm Staging22022112020.040 Why?
Workflow120228590.040 Why?
Follow-Up Studies12019392330.040 Why?
Time Factors12019401000.040 Why?
Quality of Life12018134630.030 Why?
Paclitaxel1202317250.030 Why?
Breast Neoplasms12022210720.030 Why?
Lymphatic Metastasis1202228900.030 Why?
Aged420221711610.030 Why?
Cell Nucleus1202328640.030 Why?
Receptors, Estrogen1202222420.030 Why?
Mutation12018302080.030 Why?
Phosphatidylinositol 3-Kinases1202228780.030 Why?
Receptor, erbB-21202225930.020 Why?
Lymph Nodes1202234570.020 Why?
Medical Oncology1202223390.020 Why?
Mitochondria1202336750.020 Why?
Proportional Hazards Models12022125300.020 Why?
Kidney1202370700.020 Why?
Germ-Line Mutation1201618850.020 Why?
Adult220192231060.020 Why?
Antibodies, Monoclonal1202292370.020 Why?
Delivery of Health Care1202253650.010 Why?
Antineoplastic Combined Chemotherapy Protocols12022118580.010 Why?
Treatment Outcome12022651990.010 Why?
Retrospective Studies12022815420.010 Why?
Cohort Studies12016416750.010 Why?
Aged, 80 and over12016594930.010 Why?
Male120163638550.000 Why?
Bouberhan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Co-Authors (72)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.